about
Constraining cyclic peptides to mimic protein structure motifs.Truncated and helix-constrained peptides with high affinity and specificity for the cFos coiled-coil of AP-1Comparative α-helicity of cyclic pentapeptides in water.Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.Helix Nucleation by the Smallest Known α-Helix in Water.Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins.Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potencyCyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally AbsorbedPyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors.Update 1 of: Beta-strand mimetics.Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.The antiplasmodial activity of norcantharidin analogs.Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.Flexibility versus Rigidity for Orally Bioavailable Cyclic HexapeptidesImproving on Nature: Making a Cyclic Heptapeptide Orally BioavailableParallel Solution-Phase Synthesis of Targeted Tyrphostin Libraries with Anticancer ActivityGreen chemistry approaches to the Knoevenagel condensation: comparison of ethanol, water and solvent free (dry grind) approachesHeterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activityNorcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluationSynthesis and biological evaluation of norcantharidin analogues: Towards PP1 selectivityTwists or turns: stabilising alpha vs. beta turns in tetrapeptidesA Novel Long-Range n to π* Interaction Secures the Smallest known α-Helix in WaterMirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilities
P50
Q30367509-E197C55B-F5FB-4F16-A484-7BDCB8A3F69EQ30610173-230B5E74-5390-4098-99A4-D3C6E464C119Q30820760-5A463970-C74F-4E0F-82FA-8C1435912226Q30891883-28E64A16-2D7E-414F-A018-A801F290387FQ31102104-92421594-60A7-4D66-B783-72C45C6985C5Q33227645-350E79CC-9D4E-486F-86DE-80DD6C151FC1Q33449747-41516B54-F1A6-4D2A-A632-FD13F9B9CE3AQ33567033-0F3DB138-A8D9-43B3-8CC0-128A26C1CE75Q33602739-14D52C83-3DE2-4711-A926-874B41A3CC43Q34310238-A128F489-B0D4-4870-AD3B-872EB02F4655Q34705504-5339046E-0967-4DFD-A531-6F7DAF2510DFQ37729118-FB3DC976-8D2E-40DF-A4DA-6B14A5EE3019Q39913573-281D2070-2418-40A1-99B0-4F8F3D48938DQ41934832-C449D832-FD93-4809-A98B-709D4AAC131FQ44900716-7ABB5310-FE5C-4E65-B3FB-72C0D4485394Q51339145-E1EFC165-939F-490A-9704-9296D2B8D6C1Q57080803-77CBB230-B3EF-4DF7-B327-DB7A41DB6563Q57080817-35602D8E-A090-48CE-9F77-E44329FCB503Q57976286-C470C72A-E7F8-450B-8FEB-DD79A534F4D5Q57976303-7543636E-A7CB-4301-B73A-C1986B5AD60DQ58200454-E4E4BF09-C836-45D4-8094-75D1D464DB8EQ58200460-DC4A0D0B-1613-42D6-957C-B82F940F89FFQ58200463-5E605209-B7B5-4BE0-989D-ED0E9179257CQ89940988-6047538B-7389-462A-9094-6C0B907B8CFAQ90787447-F9382D1E-453C-46D6-B99A-BFF997021C63Q90829897-98CC0047-09E6-4294-B6ED-558F96D98B14
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Timothy Hill
@ast
Timothy Hill
@en
Timothy Hill
@es
Timothy Hill
@nl
Timothy Hill
@sl
تيموثي هيل
@ar
type
label
Timothy Hill
@ast
Timothy Hill
@en
Timothy Hill
@es
Timothy Hill
@nl
Timothy Hill
@sl
تيموثي هيل
@ar
prefLabel
Timothy Hill
@ast
Timothy Hill
@en
Timothy Hill
@es
Timothy Hill
@nl
Timothy Hill
@sl
تيموثي هيل
@ar
P106
P1153
7201432314
P21
P31
P496
0000-0001-9727-9930